Cite

HARVARD Citation

    Wei, X. et al. (2018). Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD. Experimental eye research. pp. 2-11. [Online]. 
  
Back to record